75 completed. 75 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 75 | Completed 75 |
| Phase 2 | 2 | Completed 2 |
Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg - Healthy, Fasting | Phase 1 | Completed | LG Chem | 28 | 2026-06-11 | 2026-09-10 |
| A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants. balcinrenone/ dapagliflozin, quinidine - Healthy Participants | Phase 1 | Completed | AstraZeneca | 14 | 2025-05-20 | 2025-08-12 |
| In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State | Phase 1 | Completed | Cingulate Therapeutics | 25 | 2024-10-31 | 2025-08-12 |
| Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions Lamotrigine 100 MG - Fasting | Phase 1 | Completed | Desitin Arzneimittel GmbH | 24 | 2023-04-03 | 2024-01-10 |
| Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State | Phase 1 | Completed | Cingulate Therapeutics | 27 | 2022-09-14 | 2022-10-20 |
| Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions Rivaroxaban 2.5 mg Test Tablet, Rivaroxaban 2.5 mg Reference Tablet - Healthy Participants | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 64 | 2022-03-16 | 2026-09-08 |
| Intermittent Fasting and CLL/SLL Intermittent fast - Neoplasms, Leukemia, Lymphocytic, Chronic | Phase 1 | Completed | Eleah Stringer | 15 | 2021-02-03 | 2023-02-14 |
| Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting Esomeprazole, Placebo - Dyspepsia | Phase 1 / Phase 2 | Completed | University of Monastir | 500 | 2020-01-20 | 2025-02-25 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects Perindopril tert-Butylamine tablets ( Produced by Haisco), Perindopril tert-Butylamine tablets(ACERTIL®) - Healthy | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 32 | 2018-11-29 | 2020-09-21 |
| Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects Bosentan 125 mg, Tracleer 125Mg Tablet - Bioequivalence | Phase 1 | Completed | Geropharm | 64 | 2018-05-24 | 2019-09-24 |
| Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions Metformine, Glucophage® Long, Metformin - Bioequivalence | Phase 1 | Completed | Geropharm | 28 | 2017-06-15 | 2018-07-03 |
| Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects Metformin, Glucophage® - Bioequivalence | Phase 1 | Completed | Geropharm | 18 | 2017-02-14 | 2018-07-03 |
| To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers RP6530 - Healthy | Phase 1 | Completed | Rhizen Pharmaceuticals SA | 18 | 2016-02-01 | 2017-11-28 |
| Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects Dutasteride-Test product, Dutasteride-Reference product - Prostatic Hyperplasia | Phase 1 | Completed | GlaxoSmithKline | 36 | 2015-09-09 | 2018-06-19 |
| Bioequivalence Study of Sorafenib Tablet and Nexavar Nexavar, Sorafenib - Fasting | Phase 1 | Completed | Yabao Pharmaceutical Group | 36 | 2015-07-01 | 2015-11-06 |
| Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions Candesartan Cilexetil in formulation 1, Candesartan Cilexetil in formulation 2, ATACAND - Cardiovascular Disease | Phase 1 | Completed | GlaxoSmithKline | 18 | 2014-12-02 | 2018-03-12 |
| A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions Eltrombopag - Cirrhosis, Liver | Phase 1 | Completed | GlaxoSmithKline | 26 | 2014-08-28 | 2017-11-13 |
| AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects PF-04965842, PF- 04965842 - Healthy | Phase 1 | Completed | Pfizer | 12 | 2014-06-01 | 2014-08-18 |
| Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration Levodopa Carbidopa immediate release tablets - Fasted State | Phase 1 | Completed | Desitin Arzneimittel GmbH | 12 | 2014-03-01 | 2014-04-17 |
| Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue Meal, Exercise, Sestamibi - Molecular Imaging | Phase 1 | Completed | Mayo Clinic | 154 | 2013-09-01 | 2017-04-18 |
Showing 20 of 75. Sign in to see all of them.
Lecithin Cholesterol Acyltransferase Deficiency (9) · Cardiovascular Diseases (1) · Dyspepsia (1) · Feeding Behavior (1) · Inflammation (1) · Insulin Resistance (1) · Intermittent Fasting (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Cirrhosis (1) · Motor Activity (1) · Neoplasms (1) · Prostatic Hyperplasia (1) · Pulmonary Disease, Chronic Obstructive (1)
Behavior (75) · Feeding Behavior (74) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Dyslipidemias (9) · Genetic Diseases, Inborn (9) · Hypoalphalipoproteinemias (9) · Hypolipoproteinemias (9) · Lipid Metabolism Disorders (9) · Lipid Metabolism, Inborn Errors (9) · Metabolic Diseases (9) · Metabolism, Inborn Errors (9) · Nutritional and Metabolic Diseases (9) · Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Chronic Disease (2)
Doxycycline (3) · Lisinopril (3) · Metformin (3) · Ondansetron (3) · Clonazepam (2) · Clopidogrel (2) · Dexmethylphenidate Hydrochloride (2) · Dronabinol (2) · Etodolac (2) · Hydrochlorothiazide (2) · Metoprolol (2) · Olanzapine (2) · Tablets (2) · dapagliflozin (2) · recombinant methionyl human leptin (2)
Par Pharmaceutical, Inc. (18) · Dr. Reddy's Laboratories Limited (12) · IPCA Laboratories Ltd. (12) · AstraZeneca (3) · Geropharm (3) · GlaxoSmithKline (3) · Beth Israel Deaconess Medical Center (2) · Cingulate Therapeutics (2) · Desitin Arzneimittel GmbH (2) · Mutual Pharmaceutical Company, Inc. (2) · Actavis Inc. (1) · Eleah Stringer (1) · INSYS Therapeutics Inc (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · LG Chem (1)
India (20) · United States (16) · Canada (14) · Russia (3) · United Kingdom (3) · China (2) · Belgium (1) · Bulgaria (1) · Germany (1) · Indonesia (1) · Ireland (1) · Japan (1) · Jordan (1) · Mexico (1) · Thailand (1)
Dr. Hardik Dave, M.B.B.S (4) · Eric Masson, Pharm.D. (3) · Anthony R Godfrey, Pharm.D. (2) · Christian Aumais (2) · Dr. Hardik Dave, M.B.B.S. (2) · Gary Shillito (2) · Matt Brams, MD (2) · Ali Ziaee (1) · Antonio Pizzaro (1) · Antonio R. Pizarro, M.D., (1) · Benoit Girard, M.D. (1) · Christian Sicard, M.D (1) · Christos S Mantzoros, MD DSc FACP FACE (1) · Christos S Mantzoros, MD, DSc (1)
PMID 21917874, PMID 33051459, PMID 35820631, PMID 18201934, PMID 20703446, PMID 21045179, PMID 21660636, PMID 22775199, PMID 23193213, PMID 23713767, PMID 25540981, PMID 25613340, PMID 29856004, PMID 30479286, PMID 35061234, PMID 39097160, PMID 41120363
M01RR001032 (1), R01DK058785 (1), R44CA143716 (1)